Andrea Tan
Stock Analyst at Goldman Sachs
(0.99)
# 3,802
Out of 4,974 analysts
46
Total ratings
38.89%
Success rate
-11.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $114 → $142 | $145.10 | -2.14% | 11 | Aug 13, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.49 | +221.29% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $57.63 | -11.50% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $7.55 | +257.62% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $7.11 | -15.61% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $29.08 | +6.62% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $1.65 | +21.21% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $10.52 | -80.99% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $150.27 | +6.48% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $4.22 | +468.72% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.01 | +296.04% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $432.53 | -13.30% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $1.96 | +104.08% | 2 | May 24, 2022 |
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $114 → $142
Current: $145.10
Upside: -2.14%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.49
Upside: +221.29%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $57.63
Upside: -11.50%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $7.55
Upside: +257.62%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $7.11
Upside: -15.61%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $29.08
Upside: +6.62%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $1.65
Upside: +21.21%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $10.52
Upside: -80.99%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $150.27
Upside: +6.48%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $4.22
Upside: +468.72%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.01
Upside: +296.04%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $432.53
Upside: -13.30%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $1.96
Upside: +104.08%